Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 577–600 of 1,819 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Gulf War Illness
Interventions: Curcumin, Resveratrol, Stinging Nettle; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 45 Years and older
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Diet Habit, Sugar-Sweetened Beverages
Interventions: iSIPsmarter, Patient Education (PE); Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 110 Years
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Eating Disorder, Body Image
Interventions: Pride Body Project, Media Advocacy; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 453 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Covid19, Vaccine Refusal, Communication
Interventions: YourCoViDVaxFacts; Behavioral
Lead sponsor: Meharry Medical College; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Otitis Media (AOM)
Interventions: Amoxicillin, Amoxicillin-Clavulanate, Amoxicillin Placebo, Amoxicillin-Clavulanate Placebo; Drug
Lead sponsor: Nader Shaikh; Other
Eligibility: 6 Months to 36 Months
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 5
States / cities: Denver, Colorado • Durham, North Carolina • Cincinnati, Ohio + 2 more

Conditions: Stroke
Interventions: High intensity gait training in a balance challenging Movement amplification environment; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: dupilumab, Matching Placebo, ICS/LABA; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 12 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 51
States / cities: Bakersfield, California • La Jolla, California • Lancaster, California + 47 more

Conditions: Nasopharyngeal Colonization and Acute Otitis Media
Interventions: procedures; Other
Lead sponsor: Rochester General Hospital; Other
Eligibility: 6 Months to 36 Months
Enrollment: 1,320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Plaque Psoriasis
Interventions: AGN-242428, Placebo; Drug
Lead sponsor: Vitae Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 15
States / cities: Birmingham, Alabama • Tucson, Arizona • Fort Smith, Arkansas + 12 more

Conditions: Acute Kidney Injury, Hypoxic-Ischemic Encephalopathy, Caffeine
Interventions: Caffeine citrate; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 0 Hours to 24 Hours
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 2
States / cities: Little Rock, Arkansas

Conditions: Asthma
Interventions: Placebo, BI 54903, Fluticasone propionate; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 41
States / cities: Fountain Valley, California • Fullerton, California • Huntington Beach, California + 38 more

Conditions: Cancer, Skin Fibroblasts, Muscle Weakness
Interventions: Nicotinamide Riboside (NR); Dietary Supplement
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Opioid Overdose
Interventions: Opioid Rapid Resonse System (ORRS) training, Non-active opioid overdose response training; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 100 Years
Enrollment: 773 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Food Selection
Interventions: Control (QR) Labels, Low Climate Impact Labels, High Climate Impact Labels, Traffic Light Labels, Climate Grade Labels; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 6,294 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Overweight, Obesity
Interventions: LHA-delivered energy balance classes/activities; Behavioral
Lead sponsor: Nancy Schoenberg; Other
Eligibility: 8 Years and older
Enrollment: 1,250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Whitesburg, Kentucky

Conditions: Choledocholithiasis, Bile Duct Diseases, Bile Duct Carcinoma
Interventions: "Air" contrast cholangiography using carbon dioxide gas; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Sickle Cell Disease
Interventions: Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand); Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Irvine, California • Indianapolis, Indiana

Conditions: Medium-chain Acyl-CoA Dehydrogenase Deficiency
Interventions: Sodium phenylbutyrate; Drug
Lead sponsor: Jerry Vockley, MD, PhD; Other
Eligibility: 4 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Aggression, Prosocial Behavior
Interventions: media diet, nutritional intervention; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 2 Years to 4 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Tissue and Organ Procurement
Interventions: Web intervention; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years to 60 Years
Enrollment: 4,827 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Myocardial Infarction, Stroke
Interventions: Mass Media plus clinic intervention., Media; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 45 Years to 75 Years
Enrollment: 10,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Posttraumatic Stress Disorder
Interventions: Trauma Memory Reactivation, Cannabidiol (CBD) Broad-Spectrum Oil, Placebo Oil; Behavioral · Dietary Supplement
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Opioid Use
Interventions: Wiidookaage'win Facebook Group; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Psychological Distress, Suicidal Ideation
Interventions: Flourish; Device
Lead sponsor: Candice Biernesser; Other
Eligibility: 11 Years to 21 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Bay Village, Ohio • Pittsburgh, Pennsylvania

Search by objective public record fields.

Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI

iSIPsmarter: An RCT Evaluating the Efficacy of a Technology-Based Intervention to Reduce Sugary Drinks in Rural Appalachia

The Pride Body Project

COVID-19 Vaccine Hesitancy Among African Americans

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)

Walking Balance Training Post-Stroke

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.

AGN-242428 in the Treatment of Plaque Psoriasis

PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Opioid Rapid Response System: Naloxone Training in Communities

MENU Study: Online Experiment

An Intergenerational Community Based Participatory Research (CBPR) Intervention to Reduce Appalachian Health Disparities

Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP

Acupressure in Patients With Sickle Cell Disease

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Media Impact on Preschool Behavior

Online Intervention for ANHPI College Students

Testing a Community Intervention to Increase Aspirin Use

Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms

A Pilot Study Using Facebook to Support Opioid Recovery Among American Indian Women

Flourish in Schools Pilot Study